SCHEMBL31577217

SCHEMBL31577217

CNc1nc(Nc2ccc(CN3CCOCC3)nc2)cnc1-c1cncc2c1ncn2C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 3/20 0.33
▸ HRH3 Q9Y5N1 2/20 0.33
▸ FGFR3 P22607 1/20 0.33
▸ HIF1A Q16665 1/20 0.33
▸ EPAS1 Q99814 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ AOC3 Q16853 1/20 0.33
▸ CCNC P24863 2/20 0.33
▸ CDK8 P49336 2/20 0.33
▸ LCK P06239 2/20 0.33
▸ PDGFRA P16234 2/20 0.32
▸ PIK3CA P42336 2/20 0.32
▸ SYK P43405 1/20 0.32
▸ AXL P30530 1/20 0.32
▸ TYRO3 Q06418 1/20 0.32
▸ MERTK Q12866 1/20 0.32
▸ PIK3CD O00329 1/20 0.32
▸ PIK3CB P42338 1/20 0.32
▸ PIK3CG P48736 1/20 0.32
▸ LRRK2 Q5S007 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29173404 0.85 MAPK10 (0.40) SYKLRRK2
SCHEMBL30206281 0.84 HRH3 (0.37) FLT3HRH3FGFR3HIF1AEPAS1
SCHEMBL29173651 0.84 HRH3 (0.37) FLT3HRH3FGFR3HIF1AEPAS1
SCHEMBL24943841 0.84 SYK (0.38) FLT3HRH3FGFR3HIF1AEPAS1
SCHEMBL29173450 0.83 FGFR3 (0.39) FLT3HRH3FGFR3HIF1AEPAS1
SCHEMBL30206332 0.83 FGFR3 (0.39) FLT3HRH3FGFR3HIF1AEPAS1
SCHEMBL31577202 0.82 CDK1 (0.37) FLT3CCNCCDK8PDGFRAAXL
Formic Acid SCHEMBL29173273 0.81 SYK (0.36) FLT3HRH3FGFR3HIF1AEPAS1
Formic Acid SCHEMBL30205745 0.81 SYK (0.36) FLT3HRH3FGFR3HIF1AEPAS1
SCHEMBL31577214 0.81 PIK3CA (0.32) PIK3CALRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373817-B1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2025-05-21 — — EP claimed
Send feedback